GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiGen Biopharmaceuticals Holdings Ltd (ROCO:4157) » Definitions » Accounts Receivable

TaiGen Biopharmaceuticals Holdings (ROCO:4157) Accounts Receivable : NT$6.4 Mil (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is TaiGen Biopharmaceuticals Holdings Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. TaiGen Biopharmaceuticals Holdings's accounts receivables for the quarter that ended in Sep. 2024 was NT$6.4 Mil.

Accounts receivable can be measured by Days Sales Outstanding. TaiGen Biopharmaceuticals Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2024 was 67.91.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. TaiGen Biopharmaceuticals Holdings's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was NT$1.37.


TaiGen Biopharmaceuticals Holdings Accounts Receivable Historical Data

The historical data trend for TaiGen Biopharmaceuticals Holdings's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiGen Biopharmaceuticals Holdings Accounts Receivable Chart

TaiGen Biopharmaceuticals Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.77 7.31 278.28 18.41 8.98

TaiGen Biopharmaceuticals Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.13 8.98 5.39 10.01 6.41

TaiGen Biopharmaceuticals Holdings Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


TaiGen Biopharmaceuticals Holdings Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

TaiGen Biopharmaceuticals Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=6.408/8.611*91
=67.91

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), TaiGen Biopharmaceuticals Holdings's accounts receivable are only considered to be worth 75% of book value:

TaiGen Biopharmaceuticals Holdings's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1060.145+0.75 * 6.408+0.5 * 48.777-108.938
-0-0)/717.844
=1.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


TaiGen Biopharmaceuticals Holdings Accounts Receivable Related Terms

Thank you for viewing the detailed overview of TaiGen Biopharmaceuticals Holdings's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiGen Biopharmaceuticals Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 138 Xinming Road, 7th Floor, Neihu District, Taipei, TWN, 114
TaiGen Biopharmaceuticals Holdings Ltd is mainly engaged in the research and development of new drugs, including the selection of drug candidates, pre-IND trials and clinical trials. Its operating segment includes development, research and sales of new drugs, and other.

TaiGen Biopharmaceuticals Holdings Headlines

No Headlines